The latest report by IMARC Group, titled “North America Travel Vaccines Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2032“, offers a comprehensive analysis of the industry, which comprises insights into the North America travel vaccines market report. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The North America travel vaccines market size reached US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.2 Billion by 2032, exhibiting a growth rate (CAGR) of 5.7% during 2024-2032.
North America Travel Vaccines Market Overview:
Travel vaccines are immunizations administered to individuals traveling to regions where they are at risk of contracting specific infectious diseases. These vaccines work by preparing the traveler's immune system to fight infections more effectively. Types of travel vaccines include routine, recommended, and required vaccines, depending on the destination's health risks. Routine vaccines are those that are regularly updated, such as tetanus and influenza.
In contrast, recommended vaccines are specific to the risks associated with certain areas, such as yellow fever, typhoid, and hepatitis A and B. Required vaccines are mandated by some countries for entry, with yellow fever being the most common. The advantages of travel vaccines include significant reductions in the risk of illness, protection against endemic diseases, and contribution to global public health efforts by preventing the spread of infectious diseases across borders.
Request Free Sample Report: https://www.imarcgroup.com/north-america-travel-vaccines-market/requestsample
North America Travel Vaccines Market Trends:
The North America market is fueled by increased international travel, growing awareness of vaccine-preventable diseases, and growing government support for vaccination programs. Along with this, the resurgence of tourism post-pandemic, coupled with rising business travel, is enhancing the importance of travel vaccines.
Furthermore, the expansion of travel routes to exotic destinations where infectious diseases are prevalent is elevating the demand for travel vaccinations. In addition, technological advancements in vaccine development, including mRNA technology, are playing a pivotal role in driving innovation and effectiveness in the travel vaccines sector. Additionally, public health campaigns and educational programs aimed at increasing vaccination rates among travelers are positively influencing market dynamics. Moreover, the implementation of regulations requiring vaccinations for entry into certain countries is further bolstering the market. These drivers, along with the ongoing efforts to streamline vaccination services and enhance accessibility, are creating a positive market outlook.
Explore the Full Report with Charts, Table of Contents, and List of Figures: https://www.imarcgroup.com/north-america-travel-vaccines-market
Key Market Segmentation:
Market by Composition:
- Mono Vaccines
- Combination Vaccines
Market by Disease:
- Hepatitis A
- DPT
- Yellow Fever
- Typhoid
- Hepatitis B
- Measles and Mumps
- Rabies
- Meningococcal
- Varicella
- Japanese Encephalitis
- Others
Key Regions Analysed:
- United States
- Canada
- Mexico
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Key highlights of the Report:
- Market Performance (2018-2023)
- Market Outlook (2024-2032)
- COVID-19 Impact on the Market
- Porter’s Five Forces Analysis
- Strategic Recommendations
- Historical, Current and Future Market Trends
- Market Drivers and Success Factors
- SWOT Analysis
- Structure of the Market
- Value Chain Analysis
- Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
